CalciMedica, Inc. (CALC) vs PharmaCyte Biotech, Inc. (PMCB)
A side-by-side comparison of CalciMedica, Inc. and PharmaCyte Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CALC
CalciMedica, Inc.
$1.51HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
PMCB
PharmaCyte Biotech, Inc.
$0.42HealthcareDelayed quote: Oct 6, 2026, 2:37 PM EDT
Total return — CALC vs PMCB
growth of $100 · dividends reinvested · last 3yCALC -94.7% (-62.5%/yr)PMCB -87.6% (-50.2%/yr)PMCB compounded faster over this window
CALC PMCB
CALC vs PMCB: by the numbers
- •CALC is the larger company ($5M vs $4M market cap).
Metrics side by side
Valuation
| Metric | CALC | PMCB |
|---|---|---|
| P/B ratio | 0.86 | 0.16 |
Profitability
| Metric | CALC | PMCB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -385.27% | -54.15% |
| ROIC | -122.56% | -19.51% |
Growth (annualized)
| Metric | CALC | PMCB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -33.59% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.